DJIA 16,501.65 -12.72 -0.08%
NASDAQ 4,126.97 0.00 0.00%
S&P 500 1,875.39 -4.16 -0.22%
market minute promo

91.65 -0.48 (-0.52%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

FRX $91.65 -0.52%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $92.02
Previous Close $92.13
Daily Range $91.23 - $92.39
52-Week Range $35.99 - $100.88
Market Cap $24.8B
P/E Ratio 158.84
Dividend (Yield) $0.00 (0.0%)
Volume 1,402,481
Average Daily Volume 2,792,678
Current FY EPS $1.34

Sector

Healthcare

Industry

Drugs

Forest Laboratories, Inc. (FRX) Description

The Company and its subsidiaries develop, manufacture and sell both branded and generic forms of ethical drug products which require a physician's prescription, as well as non-prescription pharmaceutical products sold over-the-counter. Website: http://www.frx.com/

News & Commentary

Here's What You Need to Know About Actavis plc's Acquisition of Forest Labs

Although the price Actavis' paid for Forest Labs is far higher than it would have paid two years ago, Actavis may have still gotten a bargain.

Will Eli Lilly (LLY) Keep Its Earnings Streak Alive? - Analyst Blog

Will Celgene (CELG) Miss this Earnings Season? - Analyst Blog

Forest Laboratories Is an Option for Wealthy Investors Who Could Afford to Pay a High Premium

Update on Actavis' Acquisitions - Analyst Blog

Update on Actavis' Acquisitions - Analyst Blog

MYL, FRX And ACT, 3 Drugs Stocks Pushing The Industry Lower

Is Now The Time To Buy Ironwood Pharmaceuticals?

Bill Nygren Comments on Forest Laboratories

Regulatory Update from Forest Labs - Analyst Blog

Regulatory Update from Forest Labs - Analyst Blog

Bill Nygren Comments on Forest Laboratories

Buy Actavis - An Attractive Value And Growth Play That Is Also A Top Guru Fund Pick

See More FRX News...

FRX's Top Competitors

FRX $91.65 (-0.52%)
Current stock: FRX
JNJ $100.22 (0.04%)
Current stock: JNJ
NVS $86.17 (-0.45%)
Current stock: NVS
RHHBY $36.22 (-0.14%)
Current stock: RHHBY